Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company specializing in the development, manufacturing, and marketing of sterile liquid products. The company focuses on parenteral formulations, packaged using Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. It also manufactures a range of medical devices.

Product Portfolio:
Amanta offers a wide range of large volume parenterals (LVPs) and small volume parenterals (SVPs) across six therapeutic segments, including:

• Fluid therapy (IV fluids)
• Diluents
• Ophthalmic solutions
• Respiratory care
• Irrigation solutions
• Medical devices like first-aid solutions and eye lubricants

The company supports various closure systems (nipple head, twist-off, leur-lock, screw types) and container sizes ranging from 2ml to 1000ml.

Business Model:
Amanta operates through three strategic business units:

1. National Sales – Selling over 45 generics under its own brands via a network of 320+ distributors and stockists.
2. International Sales – Active in Africa, Latin America, the UK, and other regions with product registrations in 19 countries.
3. Product Partnering – Manufacturing for other Indian and international pharmaceutical companies, including under loan license agreements.

As of Fiscal 2025, Amanta exported branded products to 21 countries and had 47 products registered across 120 international jurisdictions.

Manufacturing & R&D:

• Location: Hariyala, District Kheda, Gujarat, India
• Facilities: 4 LVP manufacturing lines (ABFS and ISBM), 3 SVP lines (including ABFS and conventional lines)
• Certifications: GMP (India, WHO format), approvals from Cambodia, Sudan, Philippines, Zimbabwe, and DNV certification for medical devices
• Formulation & Development (F&D): In-house lab with modern equipment for developing and improving sterile liquid dosage forms

Therapeutic Categories:
Products cover a range of categories including antibiotics, antifungals, quinolones, diuretics, anti-anaerobics, ophthalmics, and respiratory medications.

Management & Team:
Led by Managing Director Bhavesh Patel, Amanta benefits from a highly experienced and professional management team. As of March 31, 2025, the company employed 123 personnel in its F&D and quality control labs.

Competitive Strengths:

• Well-established manufacturer with a diverse sterile liquid product portfolio
• Strong manufacturing infrastructure with advanced technologies (ABFS, ISBM)
• Wide domestic and international market reach
• Robust product development and regulatory compliance
• Experienced leadership and a skilled, long-serving workforce